Kissei Pharmaceutical Co., Ltd. (4547) Earnings: Operating Profit Down 48.0% YoY, Net Income Up 4.5%

Kissei Pharmaceutical Co., Ltd. (4547) announced its financial results, reporting net sales of 23,389 million yen, an increase of 5.4% compared to the same period of the previous year. On the profit front, operating profit decreased by 48.0% year-on-year to 1,095 million yen and ordinary profit declined by 25.0% to 2,185 million yen. However, profit attributable to owners of parent rose 4.5% to 4,723 million yen, securing growth in the bottom line. Earnings per share (EPS) stood at 113.95 yen, with comprehensive income reaching 3,056 million yen.

From a financial and valuation perspective, the company maintains a robust financial foundation characterized by a high equity ratio of 84.8%. Retained earnings stand at a substantial 136.83 billion yen against interest-bearing debt of only 1.25 billion yen, indicating exceptional financial safety. Meanwhile, profitability metrics show a Return on Equity (ROE) of 2.80% and a Return on Assets (ROA) of 1.76%. With an EBITDA of 1.09 billion yen, the market will likely focus on future capital efficiency strategies utilizing its solid asset base.